Insider transactions

EDGAR

Elicio Therapeutics, Inc.

Transactions reported by directors, officers and 10% owners on SEC Forms 3, 4 and 5, read from each filing’s XML. Codes and their wording are the SEC’s own.

A Form 4 is due within two business days of the transaction, so the most recent trades may not be filed yet.

Window: transactions dated on or after 2025-11-20.

Open-market purchases (code P)
0 transactions, — shares
Open-market sales (code S)
0 transactions, — shares

Totals add the filed transactions listed; they are counts of what was reported, not a measure of direction.

Showing 1–21 of 21

Insider transactions, newest first, as filed on SEC Forms 3, 4 and 5
DateReporting ownerCodeAcquired or disposedSharesPrice per share, as filedValue (derived)Shares owned afterDirect or indirectRule 10b5-1 boxNotesSource
2026-08-31 Filed 2026-09-02WILSON KAREN J Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Stock Option (Right to Buy) — underlying Common Stock (21,750) — exercise price 2.70
Acquired (A)21,7500—21,750Direct (D) No
F1
  • F1 The stock option represents the annual non-employee director equity award to the Reporting Person and shall vest and become exercisable in full on the earlier of (A) August 31, 2027, the one-year anniversary of the date of grant, and (B) the annual meeting of the Issuer's stockholders held in 2027, subject to the Reporting Person continuing to provide services to the Issuer through such vesting date. No additional equity award will be made to the Reporting Person in connection with the 2026 annual meeting of stockholders.
Open filing 0001267490-26-000010 Read from the filing’s XML Dispute this row
2026-08-31 Filed 2026-09-02ADAMS JULIAN Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Stock Option (Right to Buy) — underlying Common Stock (21,750) — exercise price 2.70
Acquired (A)21,7500—21,750Direct (D) No
F1
  • F1 The stock option represents the annual non-employee director equity award to the Reporting Person and shall vest and become exercisable in full on the earlier of (A) August 31, 2027, the one-year anniversary of the date of grant, and (B) the annual meeting of the Issuer's stockholders held in 2027, subject to the Reporting Person continuing to provide services to the Issuer through such vesting date. No additional equity award will be made to the Reporting Person in connection with the 2026 annual meeting of stockholders.
Open filing 0001230486-26-000002 Read from the filing’s XML Dispute this row
2026-08-31 Filed 2026-09-02Ashe Carol Gail Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Stock Option (Right to Buy) — underlying Common Stock (21,750) — exercise price 2.70
Acquired (A)21,7500—21,750Direct (D) No
F1
  • F1 The stock option represents the annual non-employee director equity award to the Reporting Person and shall vest and become exercisable in full on the earlier of (A) August 31, 2027, the one-year anniversary of the date of grant, and (B) the annual meeting of the Issuer's stockholders held in 2027, subject to the Reporting Person continuing to provide services to the Issuer through such vesting date. No additional equity award will be made to the Reporting Person in connection with the 2026 annual meeting of stockholders.
Open filing 0001761748-26-000002 Read from the filing’s XML Dispute this row
2026-08-31 Filed 2026-09-02Nissenson Allen Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Stock Option (Right to Buy) — underlying Common Stock (21,750) — exercise price 2.70
Acquired (A)21,7500—21,750Direct (D) No
F1
  • F1 The stock option represents the annual non-employee director equity award to the Reporting Person and shall vest and become exercisable in full on the earlier of (A) August 31, 2027, the one-year anniversary of the date of grant, and (B) the annual meeting of the Issuer's stockholders held in 2027, subject to the Reporting Person continuing to provide services to the Issuer through such vesting date. No additional equity award will be made to the Reporting Person in connection with the 2026 annual meeting of stockholders.
Open filing 0001441889-26-000002 Read from the filing’s XML Dispute this row
2026-08-31 Filed 2026-09-02Chudnovsky Yekaterina Director · 10% owner
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Stock Option (Right to Buy) — underlying Common Stock (21,750) — exercise price 2.70
Acquired (A)21,7500—21,750Direct (D) No
F1
  • F1 The stock option represents the annual non-employee director equity award to the Reporting Person and shall vest and become exercisable in full on the earlier of (A) August 31, 2027, the one-year anniversary of the date of grant, and (B) the annual meeting of the Issuer's stockholders held in 2027, subject to the Reporting Person continuing to provide services to the Issuer through such vesting date. No additional equity award will be made to the Reporting Person in connection with the 2026 annual meeting of stockholders.
Open filing 0001979324-26-000002 Read from the filing’s XML Dispute this row
2026-08-31 Filed 2026-09-02Venkatesan Jay Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Stock Option (Right to Buy) — underlying Common Stock (21,750) — exercise price 2.70
Acquired (A)21,7500—21,750Direct (D) No
F1
  • F1 The stock option represents the annual non-employee director equity award to the Reporting Person and shall vest and become exercisable in full on the earlier of (A) August 31, 2027, the one-year anniversary of the date of grant, and (B) the annual meeting of the Issuer's stockholders held in 2027, subject to the Reporting Person continuing to provide services to the Issuer through such vesting date. No additional equity award will be made to the Reporting Person in connection with the 2026 annual meeting of stockholders.
Open filing 0001413350-26-000009 Read from the filing’s XML Dispute this row
2026-08-31 Filed 2026-09-02RUFFOLO ROBERT R Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Stock Option (Right to Buy) — underlying Common Stock (21,750) — exercise price 2.70
Acquired (A)21,7500—21,750Direct (D) No
F1
  • F1 The stock option represents the annual non-employee director equity award to the Reporting Person and shall vest and become exercisable in full on the earlier of (A) August 31, 2027, the one-year anniversary of the date of grant, and (B) the annual meeting of the Issuer's stockholders held in 2027, subject to the Reporting Person continuing to provide services to the Issuer through such vesting date. No additional equity award will be made to the Reporting Person in connection with the 2026 annual meeting of stockholders.
Open filing 0001187308-26-000004 Read from the filing’s XML Dispute this row
2026-07-16 Filed 2026-07-17Connelly Robert Director · Officer: CEO, President and Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Stock Option (Right to Buy) — underlying Common Stock (186,944) — exercise price 3.20
Acquired (A)186,9440—186,944Direct (D) No
F1
  • F1 The stock option vests and becomes exercisable as to 50% of the options on July 16, 2027, the first anniversary of the grant date, and as to the remaining 50% of the options on July 16, 2028, the second anniversary of the grant date, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates.
Open filing 0001796436-26-000002 Read from the filing’s XML Dispute this row
2026-07-16 Filed 2026-07-17Haqq Christopher Officer: See Remarks
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Stock Option (Right to Buy) — underlying Common Stock (64,643) — exercise price 3.20
Acquired (A)64,6430—64,643Direct (D) No
F1
  • F1 The stock option vests and becomes exercisable as to 50% of the options on July 16, 2027, the first anniversary of the grant date, and as to the remaining 50% of the options on July 16, 2028, the second anniversary of the grant date, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates.
Open filing 0001612095-26-000002 Read from the filing’s XML Dispute this row
2026-07-16 Filed 2026-07-17DeMuth Peter Officer: Chief Scientific Officer
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Stock Option (Right to Buy) — underlying Common Stock (52,832) — exercise price 3.20
Acquired (A)52,8320—52,832Direct (D) No
F1
  • F1 The stock option vests and becomes exercisable as to 50% of the options on July 16, 2027, the first anniversary of the grant date, and as to the remaining 50% of the options on July 16, 2028, the second anniversary of the grant date, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates.
Open filing 0001979163-26-000002 Read from the filing’s XML Dispute this row
2026-07-16 Filed 2026-07-17Shah Preetam Officer: See Remarks
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Stock Option (Right to Buy) — underlying Common Stock (60,833) — exercise price 3.20
Acquired (A)60,8330—60,833Direct (D) No
F1
  • F1 The stock option vests and becomes exercisable as to 50% of the options on July 16, 2027, the first anniversary of the grant date, and as to the remaining 50% of the options on July 16, 2028, the second anniversary of the grant date, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates.
Open filing 0001787403-26-000002 Read from the filing’s XML Dispute this row
2026-02-02 Filed 2026-02-03DeMuth Peter Officer: Chief Scientific Officer
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock
Acquired (A)20,8000—21,543Direct (D) No
F1
  • F1 Represents restricted stock units (RSUs) that will vest as to 25% of the RSUs on February 2, 2027, the first anniversary of the grant date, with the remaining RSUs vesting in annual installments over a three-year period thereafter, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates. Each RSU represents the right to receive one share of common stock, par value $0.01 per share, of the Issuer.
Open filing 0001601485-26-000006 Read from the filing’s XML Dispute this row
2026-02-02 Filed 2026-02-03DeMuth Peter Officer: Chief Scientific Officer
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Stock Option (Right to Buy) — underlying Common Stock (41,600) — exercise price 8.10
Acquired (A)41,6000—41,600Direct (D) No
F2
  • F2 The stock option vests and becomes exercisable as to 25% of the options on February 2, 2027, the first anniversary of the grant date, with the remaining options vesting in monthly installments over a three-year period thereafter, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates.
Open filing 0001601485-26-000006 Read from the filing’s XML Dispute this row
2026-02-02 Filed 2026-02-03Connelly Robert Director · Officer: CEO, President and Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock
Acquired (A)73,6000—120,570Direct (D) No
F1
  • F1 Represents restricted stock units (RSUs) that will vest as to 25% of the RSUs on February 2, 2027, the first anniversary of the grant date, with the remaining RSUs vesting in annual installments over a three-year period thereafter, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates. Each RSU represents the right to receive one share of common stock, par value $0.01 per share, of the Issuer.
Open filing 0001601485-26-000010 Read from the filing’s XML Dispute this row
2026-02-02 Filed 2026-02-03Connelly Robert Director · Officer: CEO, President and Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Stock Option (Right to Buy) — underlying Common Stock (147,200) — exercise price 8.10
Acquired (A)147,2000—147,200Direct (D) No
F2
  • F2 The stock option vests and becomes exercisable as to 25% of the options on February 2, 2027, the first anniversary of the grant date, with the remaining options vesting in monthly installments over a three-year period thereafter, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates.
Open filing 0001601485-26-000010 Read from the filing’s XML Dispute this row
2026-02-02 Filed 2026-02-03Shah Preetam Officer: See Remarks
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock
Acquired (A)24,0000—24,000Direct (D) No
F1
  • F1 Represents restricted stock units (RSUs) that will vest as to 25% of the RSUs on February 2, 2027, the first anniversary of the grant date, with the remaining RSUs vesting in annual installments over a three-year period thereafter, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates. Each RSU represents the right to receive one share of common stock, par value $0.01 per share, of the Issuer.
Open filing 0001601485-26-000008 Read from the filing’s XML Dispute this row
2026-02-02 Filed 2026-02-03Shah Preetam Officer: See Remarks
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Stock Option (Right to Buy) — underlying Common Stock (47,900) — exercise price 8.10
Acquired (A)47,9000—47,900Direct (D) No
F2
  • F2 The stock option vests and becomes exercisable as to 25% of the options on February 2, 2027, the first anniversary of the grant date, with the remaining options vesting in monthly installments over a three-year period thereafter, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates.
Open filing 0001601485-26-000008 Read from the filing’s XML Dispute this row
2026-02-02 Filed 2026-02-03Haqq Christopher Officer: See Remarks
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock
Acquired (A)25,4000—57,381Direct (D) No
F1
  • F1 Represents restricted stock units (RSUs) that will vest as to 25% of the RSUs on February 2, 2027, the first anniversary of the grant date, with the remaining RSUs vesting in annual installments over a three-year period thereafter, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates. Each RSU represents the right to receive one share of common stock, par value $0.01 per share, of the Issuer.
Open filing 0001601485-26-000002 Read from the filing’s XML Dispute this row
2026-02-02 Filed 2026-02-03Haqq Christopher Officer: See Remarks
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Stock Option (Right to Buy) — underlying Common Stock (50,900) — exercise price 8.10
Acquired (A)50,9000—50,900Direct (D) No
F2
  • F2 The stock option vests and becomes exercisable as to 25% of the options on February 2, 2027, the first anniversary of the grant date, with the remaining options vesting in monthly installments over a three-year period thereafter, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates.
Open filing 0001601485-26-000002 Read from the filing’s XML Dispute this row
2025-12-09 Filed 2025-12-10DeMuth Peter Officer: Chief Scientific Officer
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Common Stock
Acquired (A)3624.41
1,596.42

Derived: shares × price per share. Exact value 1596.42.

743Direct (D) No— Open filing 0001601485-25-000130 Read from the filing’s XML Dispute this row
2025-12-09 Filed 2025-12-10DeMuth Peter Officer: Chief Scientific Officer
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Derivative security: Stock Option (Right to Buy) — underlying Common Stock (362) — exercise price 4.41
Disposed (D)3620—0Direct (D) No
F1
  • F1 The stock option vested and became exercisable as to (i) 25% of the options on the first anniversary of the grant date or December 10, 2016, and (ii) with the remaining shares vesting at a rate of 2.0833% at the end of each month thereafter.
Open filing 0001601485-25-000130 Read from the filing’s XML Dispute this row

Institutional holders (Form 13F)

Quarter ending 2026-09-30: 8,925 filings read, the latest filed 2026-11-19. Prior quarter ending 2026-06-30: 9,176 filings read.

Showing 1–50 of 92

Institutional holders, largest position first, as filed
ManagerShares or principalValue as filedChange from the prior quarterSource
SHAH CAPITAL MANAGEMENT 1,250,000 SH2,275,000 dollarsNot in the prior quarter’s filings read Open filing 0001398344-26-018061 Filed 2026-10-09 Dispute this row
Knoll Capital Management, LLC 1,211,957 SH2,205,761 dollarsUnchanged Prior quarter: 1,211,957Open filing 0001104659-26-128241 Filed 2026-11-16 Dispute this row
BlackRock, Inc. Partly reported under another manager740,259 SH1,347,272 dollarsLower by 25,746 Prior quarter: 766,005Open filing 0002012383-26-003985 Filed 2026-11-13 Dispute this row
VANGUARD CAPITAL MANAGEMENT LLC 558,997 SH1,017,375 dollarsLower by 13,154 Prior quarter: 572,151Open filing 0002100119-26-001711 Filed 2026-11-13 Dispute this row
CITADEL ADVISORS LLC Partly reported under another manager543,450 SH989,079 dollarsNot in the prior quarter’s filings read Open filing 0001104659-26-128228 Filed 2026-11-16 Dispute this row
AQR CAPITAL MANAGEMENT LLC Partly reported under another manager448,718 SH816,666 dollarsNot in the prior quarter’s filings read Open filing 0001167557-26-000324 Filed 2026-11-16 Dispute this row
GEODE CAPITAL MANAGEMENT, LLC Partly reported under another manager414,165 SH753,883 dollarsHigher by 102,811 Prior quarter: 311,354Open filing 0001214717-26-000012 Filed 2026-11-06 Dispute this row
MORGAN STANLEY Partly reported under another manager395,833 SH720,416 dollarsHigher by 370,287 Prior quarter: 25,546Open filing 0000895421-26-000309 Filed 2026-11-13 Dispute this row
UBS Group AG Partly reported under another manager236,038 SH429,589 dollarsHigher by 195,619 Prior quarter: 40,419Open filing 0001610520-26-000121 Filed 2026-11-10 Dispute this row
STATE STREET CORP Partly reported under another manager232,242 SH422,680 dollarsHigher by 52,822 Prior quarter: 179,420Open filing 0000093751-26-000747 Filed 2026-11-12 Dispute this row
RENAISSANCE TECHNOLOGIES LLC Partly reported under another manager160,550 SH292,201 dollarsNot in the prior quarter’s filings read Open filing 0001037389-26-000062 Filed 2026-11-12 Dispute this row
NORTHERN TRUST CORP Partly reported under another manager131,790 SH239,858 dollarsHigher by 1,628 Prior quarter: 130,162Open filing 0000073124-26-000067 Filed 2026-11-16 Dispute this row
VANGUARD FIDUCIARY TRUST CO 118,465 SH215,606 dollarsHigher by 30,403 Prior quarter: 88,062Open filing 0000933478-26-000017 Filed 2026-11-13 Dispute this row
VANGUARD PORTFOLIO MANAGEMENT LLC 107,954 SH196,476 dollarsHigher by 19,049 Prior quarter: 88,905Open filing 0002100121-26-001150 Filed 2026-11-13 Dispute this row
DIADEMA PARTNERS LP Option: Put 100,000 SH182,000 dollarsUnchanged Prior quarter: 100,000Open filing 0001892688-26-000170 Filed 2026-11-16 Dispute this row
JANE STREET GROUP, LLC Option: Put Partly reported under another manager82,000 SH149,240 dollarsLower by 71,600 Prior quarter: 153,600Open filing 0001595888-26-000162 Filed 2026-11-12 Dispute this row
ALLIANCEBERNSTEIN L.P. Partly reported under another manager81,280 SH147,930 dollarsUnchanged Prior quarter: 81,280Open filing 0001109448-26-000342 Filed 2026-11-16 Dispute this row
SUSQUEHANNA INTERNATIONAL GROUP, LLP Option: Put Partly reported under another manager64,400 SH117,208 dollarsLower by 25,700 Prior quarter: 90,100Open filing 0001446194-26-000009 Filed 2026-11-16 Dispute this row
GOLDMAN SACHS GROUP INC Partly reported under another manager56,677 SH103,152 dollarsNot in the prior quarter’s filings read Open filing 0000886982-26-000647 Filed 2026-11-16 Dispute this row
SUSQUEHANNA INTERNATIONAL GROUP, LLP Partly reported under another manager54,486 SH99,165 dollarsNot in the prior quarter’s filings read Open filing 0001446194-26-000009 Filed 2026-11-16 Dispute this row
Nuveen, LLC Partly reported under another manager45,121 SH82,120 dollarsHigher by 27,233 Prior quarter: 17,888Open filing 0000930413-26-003284 Filed 2026-11-10 Dispute this row
CITADEL ADVISORS LLC Option: Call Partly reported under another manager40,000 SH72,800 dollarsLower by 94,200 Prior quarter: 134,200Open filing 0001104659-26-128228 Filed 2026-11-16 Dispute this row
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 31,706 SH57,705 dollarsUnchanged Prior quarter: 31,706Open filing 0000884546-26-000417 Filed 2026-11-16 Dispute this row
Quadrature Capital Ltd Partly reported under another manager30,936 SH56,304 dollarsNot in the prior quarter’s filings read Open filing 0001651424-26-000014 Filed 2026-11-13 Dispute this row
IEQ CAPITAL, LLC 25,814 SH46,981 dollarsNot in the prior quarter’s filings read Open filing 0001779789-26-000005 Filed 2026-11-10 Dispute this row
HB Wealth Management, LLC 25,118 SH45,715 dollarsHigher by 14,655 Prior quarter: 10,463Open filing 0001172661-26-004668 Filed 2026-10-23 Dispute this row
Leonteq Securities AG 20,000 SH36,400 dollarsUnchanged Prior quarter: 20,000Open filing 0001535950-26-000048 Filed 2026-10-29 Dispute this row
XTX Topco Ltd Partly reported under another manager19,965 SH36,336 dollarsNot in the prior quarter’s filings read Open filing 0001828301-26-000009 Filed 2026-11-16 Dispute this row
MARSHALL WACE, LLP Partly reported under another manager19,671 SH35,801 dollarsNot in the prior quarter’s filings read Open filing 0001318757-26-000012 Filed 2026-11-13 Dispute this row
HRT FINANCIAL LP 19,200 SH34 dollarsNot in the prior quarter’s filings read Open filing 0001475597-26-000249 Filed 2026-11-13 Dispute this row
SIMPLEX TRADING, LLC Option: Call 18,800 SH34,216 dollarsLower by 156,900 Prior quarter: 175,700Open filing 0001488542-26-000013 Filed 2026-11-04 Dispute this row
HighTower Advisors, LLC 18,629 SH33,905 dollarsHigher by 4,963 Prior quarter: 13,666Open filing 0001085146-26-000933 Filed 2026-11-10 Dispute this row
SUSQUEHANNA INTERNATIONAL GROUP, LLP Option: Call Partly reported under another manager18,000 SH32,760 dollarsLower by 163,400 Prior quarter: 181,400Open filing 0001446194-26-000009 Filed 2026-11-16 Dispute this row
FMR LLC Partly reported under another manager17,807 SH32,409 dollarsHigher by 17,683 Prior quarter: 124Open filing 0000315066-26-002964 Filed 2026-11-10 Dispute this row
MERCER GLOBAL ADVISORS INC /ADV Partly reported under another manager16,343 SH29,745 dollarsHigher by 13,133 Prior quarter: 3,210Open filing 0000853758-26-000020 Filed 2026-11-16 Dispute this row
Mariner, LLC 16,284 SH29,638 dollarsNot in the prior quarter’s filings read Open filing 0001580642-26-007648 Filed 2026-11-12 Dispute this row
Bank of New York Mellon Corp Partly reported under another manager15,884 SH28,909 dollarsUnchanged Prior quarter: 15,884Open filing 0001390777-26-000121 Filed 2026-11-05 Dispute this row
BANK OF AMERICA CORP /DE/ Partly reported under another manager15,624 SH28,436 dollarsNot in the prior quarter’s filings read Open filing 0000070858-26-000589 Filed 2026-11-16 Dispute this row
JANE STREET GROUP, LLC Option: Call Partly reported under another manager14,900 SH27,118 dollarsLower by 17,500 Prior quarter: 32,400Open filing 0001595888-26-000162 Filed 2026-11-12 Dispute this row
RHUMBLINE ADVISERS 14,792 SH26,916 dollarsHigher by 8,111 Prior quarter: 6,681Open filing 0001115418-26-000015 Filed 2026-11-10 Dispute this row
MILLENNIUM MANAGEMENT LLC 14,385 SH26,181 dollarsNot in the prior quarter’s filings read Open filing 0001273087-26-000011 Filed 2026-11-16 Dispute this row
NEW YORK STATE COMMON RETIREMENT FUND 14,200 SH25,844 dollarsUnchanged Prior quarter: 14,200Open filing 0000810265-26-000008 Filed 2026-11-17 Dispute this row
MEYER HANDELMAN CO Partly reported under another manager13,899 SH25,296 dollarsUnchanged Prior quarter: 13,899Open filing 0000045319-26-000006 Filed 2026-10-28 Dispute this row
WEALTH ENHANCEMENT ADVISORY SERVICES, LLC 12,552 SH22,719 dollarsHigher by 580 Prior quarter: 11,972Open filing 0001214659-26-012804 Filed 2026-10-13 Dispute this row
Squarepoint Ops LLC Partly reported under another manager12,457 SH22,672 dollarsNot in the prior quarter’s filings read Open filing 0001642575-26-000012 Filed 2026-11-09 Dispute this row
DEUTSCHE BANK AG\ Partly reported under another manager11,016 SH20,049 dollarsLower by 1,636 Prior quarter: 12,652Open filing 0000948046-26-000083 Filed 2026-11-06 Dispute this row
Creative Planning 10,606 SH19,303 dollarsNot in the prior quarter’s filings read Open filing 0001540235-26-000006 Filed 2026-11-02 Dispute this row
PRICE T ROWE ASSOCIATES INC /MD/ Partly reported under another manager10,586 SH20 dollarsUnchanged Prior quarter: 10,586Open filing 0000080255-26-000736 Filed 2026-11-16 Dispute this row
Abel Hall, LLC Partly reported under another manager10,178 SH18,524 dollarsNot in the prior quarter’s filings read Open filing 0002013339-26-000005 Filed 2026-10-19 Dispute this row
MOODY LYNN LIEBERSON WALKER, LLC 10,000 SH18,200 dollarsUnchanged Prior quarter: 10,000Open filing 0000938592-26-000010 Filed 2026-10-14 Dispute this row
Managers in the prior quarter with no filing read for the latest

They may simply not have filed yet: absent from the latest quarter’s filings read is not the same as a position sold.

  • Caption Management, LLC 418,100 SH
  • TORONTO DOMINION BANK 200,000 SH
  • Caption Management, LLC 165,700 SH
  • GROUP ONE TRADING LLC 126,700 SH
  • Ikarian Capital, LLC 107,100 SH
  • Ikarian Capital, LLC 107,100 SH
  • Ikarian Capital, LLC 100,000 SH
  • BOOTHBAY FUND MANAGEMENT, LLC 32,400 SH
  • BOOTHBAY FUND MANAGEMENT, LLC 32,400 SH
  • Sixth Street Partners Management Company, L.P. 31,706 SH
  • BOOTHBAY FUND MANAGEMENT, LLC 30,690 SH
  • CITADEL ADVISORS LLC 15,000 SH
  • RAYMOND JAMES FINANCIAL INC 12,720 SH
  • Summit Financial, LLC 10,005 SH
  • GROUP ONE TRADING LLC 2,100 SH
  • NATIONAL BANK OF CANADA /FI/ 100 SH
  • NATIONAL BANK OF CANADA /FI/ 1 SH
  • Form 13F covers long positions in Section 13(f) securities only: no short positions and no securities outside that list.
  • Reports for quarters ending before 2013-06-30 were filed as plain text and are not read.
  • A manager that has not yet filed for the latest quarter is absent, not at zero; filings are due up to 45 days after quarter end.
  • A change is the difference between two quarter-end snapshots, not a trade.
  • A position reported under another manager may also appear in that manager’s filing; rows are not added together.
  • Holdings the securities list cannot place with this company, or places ambiguously, are not shown.

Trades by members of Congress

Periodic transaction reports filed by U.S. House members that name this company’s stock. Dates and amounts are as filed.

No House member’s trade in this company is placed in the store. A trade not yet filed or not linked to a company is absent, not zero.

5% holders (Schedule 13D and 13G)

Schedules filed in the SEC’s structured format (late 2024 onward) are read here. Earlier schedules are free text and are not read.

5% holders, newest event first, as filed
HolderPercent of classShares heldEvent dateFormSource
Moti Investments LLC Common Stock, par value $0.01 per share6.11,408,892.0007/01/2026 Filed 2026-07-16SCHEDULE 13GOpen filing 0002145902-26-000001 Dispute this row
Knoll Capital Management, LLC Common Stock, par value $0.01 per share5.31,211,957.0007/01/2026 Filed 2026-07-08SCHEDULE 13G/AAmendment 1Open filing 0001104659-26-081751 Dispute this row
Fred Knoll Common Stock, par value $0.01 per share5.31,211,957.0007/01/2026 Filed 2026-07-08SCHEDULE 13G/AAmendment 1Open filing 0001104659-26-081751 Dispute this row
Gakasa Holdings, LLC Common Stock, par value $0.01 per share5.31,211,957.0007/01/2026 Filed 2026-07-08SCHEDULE 13G/AAmendment 1Open filing 0001104659-26-081751 Dispute this row
Actyus Private Equity SGIIC, S.A. Common Stock, par value $0.01 per share1.6268,564.0009/30/2025 Filed 2025-10-07SCHEDULE 13G/AAmendment 2Open filing 0002050492-25-000003 Dispute this row

Percent is of the class the filing names, as the holder stated it. Members of a group each report the group’s shares, so rows are not added together.

What was read

2,620,749 filings read, dated 2004-06-14 to 2026-11-19: Forms 3, 3/A, 4, 4/A, 5, 5/A.

Years can be incomplete while the archive is still being read. A year with few filings here is not a statement that few were made.

Filings read, by filing year
Filing yearFilings read
201537,836
2016222,642
2017222,009
2018223,345
2019216,482
2020226,343
2021249,835
2022231,682
2023229,674
2024234,045
2025235,520
2026263,123

Filings made before the SEC required XML are listed, not extracted.

Back to Elicio Therapeutics, Inc.